![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, June 27, 2018 11:47:22 AM
This is from Paul K.
We are planning to submit both the 510(k) for post operative pain and an application to participate in the FDA's Innovation Challenge. The participation in the Innovation Challenge presents the opportunity to get an indication of use to mitigate opioid use.
We do not have a schedule yet for the Allay product.
![](http://investorshub.advfn.com/uimage/uploads/2018/5/23/oiwblactipatch_airplane.jpg)
![](http://investorshub.advfn.com/uimage/uploads/2018/5/9/z[prqactipatch_steve43.jpg)
![](http://investorshub.advfn.com/uimage/uploads/2018/4/30/blqaoactipatch_familyguy.jpg)
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM